Company Search:
Advanced Search
Sponsored Links
Sangamo Therapeutics Inc Company Snapshot
Sangamo Therapeutics Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sangamo Therapeutics Inc with three other companies in this sector in the United States: Agenus Incorporation (2016 sales of $22.57 million of which 100% was Pharmacl preparations), Novavax, Inc. ($15.35 million of which 100% was Pharmaceutical Products), and Idera Pharmaceuticals, Inc. ($16.20 million of which 100% was Novel Therapeutics).

Sales Analysis. Sangamo Therapeutics Inc reported sales of $19.39 million for the year ending December of 2016. This represents a sharp decrease of 51.0% versus 2015, when the company's sales were $39.54 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Sangamo Therapeutics Inc
  Stock Performance Chart for Sangamo Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 18.30
(Figures in U.S. Dollars)
1 Week 6.4%   13 Weeks 11.9%  
4 Weeks 22.4%   52 Weeks 315.9%  
Sangamo Therapeutics Inc Key Data:
  Ticker: SGMO Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 19,389,000
(Year Ending Jan 2017).
Employees: 131
  Currency: U.S. Dollars Market Cap: 1,546,733,403
  Fiscal Yr Ends: December Shares Outstanding: 84,520,951
  Share Type: Common Closely Held Shares: 1,596,471
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.